<?xml version="1.0" encoding="UTF-8"?>
<p id="p0135">ALX-0171 is a trimeric domain Nanobody based-drug that binds the antigenic site II of RSV F protein. ALX-0171 completely inhibited replication under detection rate. The function of ALX-0171 in virus titer removal from nasal and lung is more effective than palivizumab, a humanized monoclonal antibody 
 <xref rid="b0350" ref-type="bibr">[70]</xref>. Development of VHH based-drug against human immunodeficiency virus-1 (HIV-1) 
 <xref rid="b0355" ref-type="bibr">[71]</xref>, influenza viruses 
 <xref rid="b0360" ref-type="bibr">[72]</xref>, hepatitis C virus (HCV) 
 <xref rid="b0365" ref-type="bibr">[73]</xref> are ongoing.
</p>
